![]() |
市場調查報告書
商品編碼
1017607
美容醫療的全球市場:現狀分析與未來預測 (2021年∼2027年)Aesthetic Medicine Market: Current Analysis and Forecast (2021-2027) |
從治療類型看全球美容醫學市場,隆胸手術的佔有率很高。然而,如今非侵入性和微創性的普及正在增加。按地區劃分,北美國家是最大的市場。
本報告提供全球美容醫療的市場相關分析,提供市場概要和背景情況·相關法規,市場基本結構和最新形勢,主要的促進·阻礙因素,整體市場規模趨勢預測,各產品·各終端用戶·各地區的詳細趨勢,市場競爭狀態,主要企業簡介等調查。
Aesthetic medicine consists of all medical procedures that aim to improve one's physical appearance. They can be performed using non-invasive and minimally invasive procedures. Dermatologists and plastic surgeons are the main specialists in aesthetic medicines sector; however, other specialists also offer services to address the aesthetic needs of the patients. These procedures can be performed under local anaesthesia while some do not require anaesthesia at all. Plastic in plastic surgery comes from the Greek word plastikos, which means mold or to give form. It is a surgical specialty which enhances a person's appearance and reconstructs their facial and body tissue defects which could be caused by trauma, illness or can be birth disorders. Plastic surgery can be performed in any part of the anatomy except the central nervous system. In 2020, 2.3 million cosmetic surgical procedures were performed, a decline of 14% compared to 2019 in the US. In 2019, there were 2.67 million Cosmetic Surgical Procedures were performed in the US. Therefore, these treatments are becoming popular, especially the quick, non-invasive procedures which contain very little risk. In 2020, 13.3 million Cosmetic Minimally Invasive Procedures were conducted in the US alone.
Based on procedure type, the market is bifurcated into invasive (breast augmentation, liposuction, nose reshaping, tummy tuck) and non-invasive procedures (botox injections, chemical peel, laser hair removal). Amongst procedure type, the breast augmentation segment generated revenue of US$ XX million in 2020 and is expected to reach US$ XX million by 2027 growing at a CAGR of XX% from 2021-2027. Based on product, the aesthetic medicine market is fragmented into facial aesthetic products, body contouring devices, breast implants, hair removal devices, skin aesthetic devices, and others. Breast implants segment accounted for XX% share in 2020. Based on end-user, the aesthetic medicine market is fragmented into clinics, hospitals, and medical spas, beauty centres and home care. The clinics, hospitals and medical spas segment generated revenue of US$ XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period.
For a better understanding of the market and adoption of Aesthetic medicine, detailed analysis is conducted for major regions including North America (US, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, UK, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America dominated the market in 2020, with XX% share. The dominance can be attributed to the presence of well-established players in the region, rising healthcare investment by the companies and government, etc. Some of the major players operating in the market Allergan, Galderma Laboratories, Merz Pharmaceuticals, Alma Lasers, Johnson & Johnson, Anika Therapeutics, Lumenis, Cynosure, Cutera, and Solta Medical.